Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Animal : an International Journal of Animal Bioscience|August 8, 2025
Review: The lesser mealworm as a nutrient pioneer: Pathways to sustainable insect farmingG V Baliota, C I Rumbos, N Gianotten, et al.
Anti-Cancer Drugs|July 11, 2003
Cisplatin-induced encephalopathy and seizuresN Steeghs, F E de Jongh, P A E Sillevis Smitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2019
Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumorsK M Heinhuis, W Ros, M Kok, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2018
Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort studyJ J Koldenhof, N A G Lankheet, N Steeghs, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2026
The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trialsA C Kanhailal, M J J Lucassen, T Schutte, et al.
Clinical and Translational Science|October 13, 2023
The use of microtracers in food-effect trials: An alternative study design for toxic drugs with long half-lives exemplified by the case for alectinibL T van der Heijden, N Steeghs, J H Beijnen, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2020
Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimizationR B Verheijen, E L Swart, J H Beijnen, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2017
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimizationR B Verheijen, L E Swart, J H Beijnen, et al.
Therapeutic Drug Monitoring|March 19, 2013
Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoringNienke A G Lankheet, N Steeghs, H Rosing, et al.
British Journal of Haematology|August 16, 2005
C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolismN Steeghs, R J Goekoop, R W L M Niessen, et al.
Pageof 5